Synergistic anti-tumour activity of sorafenib in combination with pegylated resveratrol is mediated by Akt/mTOR/p70S6k-4EBP-1 and c-Raf7MEK/ERK signaling pathways

Ligang Wang(Zhejiang Provincial People's Hospital), Litao Sun(Zhejiang Provincial People's Hospital)

Heliyon

August 1, 2023

10.1016/j.heliyon.2023.e19154

Cited by 2

Related Papers

No related papers found

Powered by citation graph analysis